Viewing Study NCT06334120


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:29 AM
Study NCT ID: NCT06334120
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-03-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module